org placeholder image

Matthew Denholtz

Associate Director, Molecular Engineering at Fate Therapeutics

  • LinkedIn

Genomics and bioinformatics.

Read More

map
FATE THERAPEUTICS

FATE THERAPEUTICS

  • Employees count Employees 201-500
  • Revenue Revenue 50 Million to 100 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Fate Therapeutics Org Chart and Mapping

VP-Level
VP-Level
Employees

Ramesh Janani

Director, Analytical Development

Cynthia Rock

Business Planning & Sourcing Manager

Jerome Bressi

Senior Vice President, Regulatory & Quality

Wei Zhao

Senior Director of Data Science

Matthew Denholtz

Associate Director, Molecular Engineering

Kyle Brito

Materials Management Associate III

Helena Filippone

Senior Manager, Analytical QA

Frequently Asked Questions Regarding Matthew Denholtz

Answer: Matthew Denholtz works for Fate Therapeutics as Associate Director, Molecular Engineering

Answer: Matthew Denholtz’s role in Fate Therapeutics is Associate Director, Molecular Engineering

Answer: Matthew Denholtz's email address is m***@gmail.com

Answer: Matthew Denholtz's business email address is m****@fatetherapeutics.com

Answer: Matthew Denholtz’s direct phone number is (***)-***-****

Answer: Matthew Denholtz works in the industry of: Biotechnology

Answer: Matthew Denholtz is the current Associate Director, Molecular Engineering at Fate Therapeutics.... Read More

Answer: Matthew Denholtz works Fate Therapeutics located at 3535 General Atomics Ct Ste 200, San Diego, California, 92121, United States

Answer: Fate Therapeutics's Associate Director, Molecular Engineering is Matthew Denholtz

Answer: Matthew Denholtz contact details:

  • Phone number  :  (***)-***-****
  • Email  :  m****@fatetherapeutics.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access